Navamedic ASA is a Nordic pharmaceutical company headquartered in Oslo, Norway, specializing in the supply of high-quality prescription drugs, consumer health products, and medical nutrition to hospit... Navamedic ASA is a Nordic pharmaceutical company headquartered in Oslo, Norway, specializing in the supply of high-quality prescription drugs, consumer health products, and medical nutrition to hospitals and pharmacies. Incorporated in 2002 and listed on the Oslo Stock Exchange since 2006, it focuses on addressing key public health challenges including obesity, Parkinson’s disease, antibiotics, addiction treatment, metabolism, cardiology, urology, and women’s health. The company operates across the Nordic countries—Norway, Sweden, Denmark, and Finland—along with the Benelux region, the Baltics, the UK, and Greece, employing around 42 professionals. Navamedic’s portfolio features both Rx and OTC pharmaceuticals, medical devices, food supplements, and cosmetics, sourced through strategic distribution agreements and in-licensing deals. Notable recent developments include the acquisition of the dne pharma business in 2025, bolstering its addiction treatment offerings, and innovations like advanced Parkinson’s care solutions for personalized dosing. With sales reaching 531 million NOK in 2024 and ambitions for further growth toward 1 billion NOK in revenues, Navamedic plays a vital role as a preferred partner for international firms entering Northern European markets, leveraging local expertise for regulatory compliance and market access.
Disclosures of Navamedic
Explore Navamedic's complete collection of publicly available corporate disclosures, including annual
reports, sustainability reports, financial statements, ESG data spreadsheets, and related web
publications. Each document is sourced directly from Navamedic's official channels and fully
traceable to its official company sources.
The table below lists all of Navamedic's' corporate disclosure by name and reporting period, ensuring
full transparency and easy access.
If you want to search across Navamedic's' disclosures for specific data or insights, use our Disclosure Search.
Name
Reporting Period
ESG Report
2024
Annual Report
2024
ESG Report
2023
Annual Report
2023
ESG Report
2022
Annual Report
2022
Annual Report
2021
Annual Report
2020
Annual Report
2019
Real-Time Disclosures Datafeed
Get Notified Within Seconds of New Corporate Disclosures
Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies
publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or
analytical workflows?